African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5181

Full Length Research Paper

Genotyping of high-risk human papilloma virus (HR-HPV) and its role in cervical cancer among suspected women at reproductive age

Moneira A. Mansour
  • Moneira A. Mansour
  • Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
  • Google Scholar
Mogahid M. Elhassan
  • Mogahid M. Elhassan
  • Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
  • Google Scholar
Faris M. Eltom
  • Faris M. Eltom
  • Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
  • Google Scholar
Hala M. Yousif
  • Hala M. Yousif
  • Department of Pathology, College of Medicine, Taibah University, Al-Madinaah Al-Munawarah, KSA.
  • Google Scholar
Hashim M. Missawi
  • Hashim M. Missawi
  • Department of Clinical Pathology, Maternity and Children Hospital Ministry of Health, Al-Madinah Al Munawarah, KSA.
  • Google Scholar
Eshraga O. Mohamed
  • Eshraga O. Mohamed
  • Department of Microbiology, College of Medical Laboratory Science, Shandi University, Shandi, Sudan.
  • Google Scholar
Ibrahim B. Elemam
  • Ibrahim B. Elemam
  • Department of Microbiology, College of Medical Laboratory Science, Shandi University, Shandi, Sudan.
  • Google Scholar
Bahjat S. Farsi
  • Bahjat S. Farsi
  • Department of Clinical Pathology, Maternity and Children Hospital Ministry of Health, Al-Madinah Al Munawarah, KSA.
  • Google Scholar


  •  Received: 04 November 2017
  •  Accepted: 14 December 2017
  •  Published: 28 December 2017

References

Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR (2011). Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int. J. Gynecol. Cancer 21:907-910.
Crossref

 

Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K (2011). Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol. Oncol. 121:522-526.
Crossref

 
 

Altaf FJ (2008). Cervical cancer screening with pattern of pap smear. Rev. Multicent. Stud. 27(10):1498-502.

 
 

Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202:1789-1799.
Crossref

 
 

Darnel AD, Wang D, Ghabreau L, Yasmeen A, Sami S, Akil N, Al Moustafa AE (2010). Correlation between the presence of high‐risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer. Clin. Microbiol. Infect. 16(3):262-266.
Crossref

 
 

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol. 11(11):1048-5610.
Crossref

 
 

Enerly E, Bonde J, Schee K, Pedersen H, Lonnberg S, Nygard M (2016). Self-sampling for human Papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme. PLoS One 11(4): e0151978.
Crossref

 
 

Farnsworth A (2011). Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: An Australian perspective. Acta Cyto. 55:307-312.
Crossref

 
 

Ghazi A (2014). HPV Infection in Cervical and Other Cancers in Saudi Arabia. Implication for Prevention and Vaccination. Oncol. 4:65.

 
 

Ghazi A, Najla A, Medhat E, Ismail A (2013). HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infec. Agen. Can. 20138:15.

 
 

Hammouda D, Clifford GM, Pallardy S, Ayyach G, Chekiri A, Boudrich A, Snijders PJ, van Kemenade FJ, Meijer CJ, Bouhadef A (2011). Human papillomavirus infection in a population-based sample of women in Algiers, Algeria. Int. J. Cancer. 128:2224-2229.
Crossref

 
 

Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC (2012). Human papillomavirus infection among young adolescents in India: impact of vaccination. J. Med. Virol.84:298-305.
Crossref

 
 

ICO Information Centre on HPV and Cancer (2010). Human Papillomavirus and Related Cancers Infection. ICO HPV Information Centre, Institut Català d'Oncologia, Avda. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat (Barcelona, Spain) 16(3):262-6.

 
 

Khorasanizadeh F, Hassanloo J, Khaksar N, Taheri SM, Marzaban M, Rashidi BH, Sari AA, Zendehdel K (2012). Epidemiology of cervical cancer and human papilloma virus infection among Iranian women-Analyses of national data and systematic review of the literature. Gynecol. Oncol. 128:277-281.
Crossref

 
 

Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D (2000). Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis. Am. J. Epidemiol. 168:123-137.
Crossref

 
 

Lam JUH, Elfstro KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J (2018). High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders British Journal of Cancer 118:138-144.
Crossref

 
 

Lowy DR, Schiller JT (2015). Reducing HPV-associated cancer globally. Cancer Prev. Res. (Philadelphia) 5(1):18-23.
Crossref

 
 

Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. (2016). The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome Microbiome. 14(1):58.
Crossref

 
 

McLaughlin-Drubin M, Munger K (2008). Viruses associated with human cancer. Biochim Biophys Acta. 1782:127-50.
Crossref

 
 

Ostor AG (1993). The natural history of cervical intra epithelial neoplasia of the uterine cervix. Int. Gynecol. Pathol. 12:186-92.
Crossref

 
 

Parkin D (2002). The global health burden of infection associated cancers in the year. Int. J. Cancer. 118:3030-3044.
Crossref

 
 

Poljak M, Kovanda A, Kocjan BJ, Seme K, Jancar N, Vrtacnik-Bokal E (2009). The Abbott RealTime High Risk HPV test: Comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test. Acta Dermatovenerol. Alp. Panon. Adriat. 18:94-103.

 
 

Sambrook J, Russell D, Gola J (2001). Molecular cloning, third ed, A laboratory manual. 1:32-34.

 
 

Sankaranarayan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA (2009). HPV screening for cervical cancer in Rural India. N. Engl. J. Med. 360:1385-1394.
Crossref

 
 

Sawaya GF, Kerlikowske K, Lee NC,Gildengorin G, Washington AE (2000). Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet. Gynecol. 96(2):219-23.

 
 

Saudi Cancer Report (SCR) (2011). Cancer Incidence and Survival Report: Saudi Arabia 2007. Special Edition. Saudi Cancer Registry 2011; Riyadh, Kingdom of Saudi Arabia: Ministry of Health. Available at: 

View

 
 

Sin HL, Vigliotti JS, Vigliotti VS, Jones W (2014). From human papillomavirus (HPV) detection to cervical cancer prevention in clinical practice. Cancers. 6(4):2072-2099.
Crossref

 
 

Stanley MA (2009). Immune responses to human papilloma viruses. Indian J. Med. Res. 130:266-276.

 
 

Sultana F, English DR, Simpson JA, Drennan KT, Mullins R, Brotherton JM, Wrede CD, Heley S, Saville M, Gertig DM (2016) Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia. Int J Cancer 139(2):281-290.
Crossref

 
 

Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'leary J, Joura EA, Rosenlund M, Colau B (2013). Differences in human papillomavirus type distribution in high‐grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int. J. Cancer. 132(4):854-867.
Crossref

 
 

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189(1):12-19.
Crossref

 
 

PubMedWHO/ICO (2012). Information center on human papilloma virus (HPV) and cervical cancer 2011. 

View [(accessed on 2 May 2014)]. 84: 298-305.